VAXIION THERAPEUTICS INC has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, Canada and Japan. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are XANTOS BIOMEDICINE AG, ABBOTT BIOLOGICALS BV and DE STAAT DER NEDERLANDEN VERT DOOR DE MINI VAN VWS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 4 | |
#3 | Japan | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | China | 3 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Climate change adaptation technologies | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Peptides | |
#6 | Fermentation | |
#7 | Analysing materials | |
#8 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Giacalone Matthew J | 10 |
#2 | Berkley Neil | 7 |
#3 | Tsuji Shingo | 7 |
#4 | Sabbadini Roger A | 5 |
#5 | Maloy Stanley | 5 |
#6 | Surber Mark | 4 |
#7 | Matthew J Giacalone | 4 |
#8 | Surber Mark W | 4 |
#9 | Klepper Robert | 3 |
#10 | Stanley Maloy | 3 |
Publication | Filing date | Title |
---|---|---|
WO2014055682A1 | Immunomodulatory minicells and methods of use | |
CN105483067A | Method for manufacturing semiconductor substrate | |
WO2006055024A2 | Minicells as vaccines | |
US7396822B2 | Immunogenic minicells and methods of use | |
US7183105B2 | Eubacterial minicells and their use as vectors for nucleic acid delivery and expression |